Naude James, Wang Meng, Leon Rebeca, Smith Eric, Ismail Zahinoor
University of British Columbia, Vancouver, British Columbia, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
medRxiv. 2024 Feb 13:2024.02.11.24302665. doi: 10.1101/2024.02.11.24302665.
Mild Behavioral Impairment (MBI) leverages later-life emergent and persistent neuropsychiatric symptoms (NPS) to identify a high-risk group for incident dementia. Phosphorylated tau (p-tau) is a hallmark biological manifestation of Alzheimer disease (AD). We investigated associations between MBI and tau accumulation in early-stage AD cortical regions. In 442 Alzheimer's Disease Neuroimaging Initiative participants with normal cognition or mild cognitive impairment, MBI status was determined alongside corresponding p-tau and A. Two meta-regions of interest were generated to represent Braak I and III neuropathological stages. Multivariable linear regression modelled the association between MBI as independent variable and tau tracer uptake as dependent variable. Among A positive individuals, MBI was associated with tau uptake in Braak I ( =0.45(0.15), <.01) and Braak III ( =0.24(0.07), <.01) regions. In A negative individuals, MBI was not associated with tau in the Braak I region (p=.11) with a negative association in Braak III (=.01). These findings suggest MBI may be a sequela of neurodegeneration, and can be implemented as a cost-effective framework to help improve screening efficiency for AD.
轻度行为障碍(MBI)利用晚年出现并持续存在的神经精神症状(NPS)来识别新发痴呆的高危人群。磷酸化tau蛋白(p-tau)是阿尔茨海默病(AD)的标志性生物学表现。我们研究了MBI与早期AD皮质区域tau蛋白积累之间的关联。在442名认知正常或轻度认知障碍的阿尔茨海默病神经影像学计划参与者中,确定了MBI状态以及相应的p-tau和A。生成了两个感兴趣的元区域来代表Braak I和III神经病理阶段。多变量线性回归将MBI作为自变量与tau示踪剂摄取作为因变量之间的关联进行建模。在A阳性个体中,MBI与Braak I区域(β = 0.45(0.15),p <.01)和Braak III区域(β = 0.24(0.07),p <.01)的tau摄取相关。在A阴性个体中,MBI与Braak I区域的tau无关联(p = 0.11),而在Braak III区域呈负相关(p =.01)。这些发现表明MBI可能是神经退行性变的后遗症,并且可以作为一种具有成本效益的框架来帮助提高AD的筛查效率。